1. Home
  2. GEVO vs CMPS Comparison

GEVO vs CMPS Comparison

Compare GEVO & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEVO
  • CMPS
  • Stock Information
  • Founded
  • GEVO 2005
  • CMPS 2020
  • Country
  • GEVO United States
  • CMPS United Kingdom
  • Employees
  • GEVO N/A
  • CMPS N/A
  • Industry
  • GEVO Major Chemicals
  • CMPS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEVO Industrials
  • CMPS Health Care
  • Exchange
  • GEVO Nasdaq
  • CMPS Nasdaq
  • Market Cap
  • GEVO 354.6M
  • CMPS 364.9M
  • IPO Year
  • GEVO 2011
  • CMPS 2020
  • Fundamental
  • Price
  • GEVO $1.47
  • CMPS $4.33
  • Analyst Decision
  • GEVO Buy
  • CMPS Strong Buy
  • Analyst Count
  • GEVO 2
  • CMPS 7
  • Target Price
  • GEVO $7.58
  • CMPS $17.83
  • AVG Volume (30 Days)
  • GEVO 4.9M
  • CMPS 2.5M
  • Earning Date
  • GEVO 08-11-2025
  • CMPS 07-31-2025
  • Dividend Yield
  • GEVO N/A
  • CMPS N/A
  • EPS Growth
  • GEVO N/A
  • CMPS N/A
  • EPS
  • GEVO N/A
  • CMPS N/A
  • Revenue
  • GEVO $42,034,000.00
  • CMPS N/A
  • Revenue This Year
  • GEVO $1,022.79
  • CMPS N/A
  • Revenue Next Year
  • GEVO $12.26
  • CMPS N/A
  • P/E Ratio
  • GEVO N/A
  • CMPS N/A
  • Revenue Growth
  • GEVO 145.38
  • CMPS N/A
  • 52 Week Low
  • GEVO $0.48
  • CMPS $2.25
  • 52 Week High
  • GEVO $3.39
  • CMPS $8.54
  • Technical
  • Relative Strength Index (RSI)
  • GEVO 52.84
  • CMPS 58.21
  • Support Level
  • GEVO $1.43
  • CMPS $4.21
  • Resistance Level
  • GEVO $1.58
  • CMPS $4.68
  • Average True Range (ATR)
  • GEVO 0.09
  • CMPS 0.29
  • MACD
  • GEVO -0.01
  • CMPS 0.11
  • Stochastic Oscillator
  • GEVO 36.36
  • CMPS 73.80

About GEVO Gevo Inc.

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Share on Social Networks: